Interleukin-33 from oligodendrocytes sustains effector differentiation of tissue-resident CD8+ T cells and is a druggable target in CNS autoimmune diseaseNicolas Fonta, Doron Merkler|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0